secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001493152-24-041362
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo updates corporate presentation; no specific changes disclosed in filing extract
--------------------------------------------------------------------------------

- Company furnished an updated Corporate Presentation as Exhibit 99.1 under Item 7.01.
- Presentation content is not included in the provided text; details of updates are unknown.
- No forward-looking statements or material financial data were available for review.
- Investors should request the full presentation from the company for substantive changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/0001493152-24-041362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer